| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
as a Candidate Target in the Progression of Human Prostate Cancer
1 Departments of Genitourinary Medical Oncology,
2 Cancer Biology, and
3 Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Direct screening of combinatorial peptide libraries in patients may allow the identification of ligands that target biochemical differences in the endothelium of blood vessels. In a screening performed in a patient, we selected and isolated a mimic motif of interleukin 11 (IL-11) from prostate biopsies after an i.v. administration of a phage display peptide library. We also demonstrated that the IL-11 phage mimic (displaying the cyclic nonapeptide CGRRAGGSC) bound specifically to a corresponding IL-11 receptor (IL-11R). Here we show that IL-11R is a potential target for intervention in human prostate cancer through morphological and functional analyses. First, a comprehensive serial immunohistochemical analysis of primary and metastatic prostate cancer samples showed increased stage-specific expression of IL-11R during disease progression. Second, a proapoptotic peptide was specifically targeted and internalized through this functional IL-11R-based ligand-receptor pair: treatment of prostate cancer cells in vitro with a proapoptotic peptide guided by the CGRRAGGSC peptide to the IL-11R resulted in dose-dependent apoptosis. Together, these data indicate that the IL-11R is a candidate target for translational clinical trials against advanced and metastatic prostate cancer. Moreover, our results illustrate the ability of direct combinatorial screening systems in cancer patients for identification of relevant targets in the context of human disease.
This article has been cited by other articles:
|
|
 |
|
  M. Obeid Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin-inducer peptides Mol. Cancer Ther., September 1, 2009; 8(9): 2693 - 2707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Giordano, J. K. Edwards, R. M. Tuder, W. Arap, and R. Pasqualini Combinatorial Ligand-directed Lung Targeting Proceedings of the ATS, August 15, 2009; 6(5): 411 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. O. Lewis, M. G. Ozawa, M. T. Deavers, G. Wang, T. Shintani, W. Arap, and R. Pasqualini The Interleukin-11 Receptor {alpha} as a Candidate Ligand-Directed Target in Osteosarcoma: Consistent Data from Cell Lines, Orthotopic Models, and Human Tumor Samples Cancer Res., March 1, 2009; 69(5): 1995 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Mintz, M. Cardo-Vila, M. G. Ozawa, A. Hajitou, R. Rangel, L. Guzman-Rojas, D. R. Christianson, M. A. Arap, R. J. Giordano, G. R. Souza, et al. An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment PNAS, February 17, 2009; 106(7): 2182 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nishimura, S. Takahashi, H. Kamikatahira, Y. Kuroki, D. E. Jaalouk, S. O'Brien, E. Koivunen, W. Arap, R. Pasqualini, H. Nakayama, et al. Combinatorial Targeting of the Macropinocytotic Pathway in Leukemia and Lymphoma Cells J. Biol. Chem., April 25, 2008; 283(17): 11752 - 11762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A.H. Jarvinen and E. Ruoslahti Molecular Changes in the Vasculature of Injured Tissues Am. J. Pathol., August 1, 2007; 171(2): 702 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Kolonin, J. Sun, K.-A. Do, C. I. Vidal, Y. Ji, K. A. Baggerly, R. Pasqualini, and W. Arap Synchronous selection of homing peptides for multiple tissues by in vivo phage display FASEB J, May 1, 2006; 20(7): 979 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J. Yao, M. G. Ozawa, A. S. Varner, I. M. Kasman, Y. H. Chanthery, R. Pasqualini, W. Arap, and D. M. McDonald Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels. Cancer Res., March 1, 2006; 66(5): 2639 - 2649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Kolonin, L. Bover, J. Sun, A. J. Zurita, K.-A. Do, J. Lahdenranta, M. Cardo-Vila, R. J. Giordano, D. E. Jaalouk, M. G. Ozawa, et al. Ligand-Directed Surface Profiling of Human Cancer Cells with Combinatorial Peptide Libraries Cancer Res., January 1, 2006; 66(1): 34 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Oh, I. Mohiuddin, Y. Sun, J. B. Putnam Jr, W. K. Hong, W. Arap, and R. Pasqualini Phenotypic Diversity of the Lung Vasculature in Experimental Models of Metastases Chest, December 1, 2005; 128(6_suppl): 596S - 600S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Oh, I. Mohiuddin, Y. Sun, J. B. Putnam Jr, W. K. Hong, W. Arap, and R. Pasqualini Phenotypic Diversity of the Lung Vasculature in Experimental Models of Metastases Chest, December 1, 2005; 128(6_suppl): 596S - 600S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. McCarty Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
